The health care company, led by CEO Sarah London, focuses on insurance plans offered through Medicaid and the Affordable Care Act. Revenue was up 15% in 2022 from the previous year.
- Centene’s $2.2 billion acquisition of behavioral-health specialist Magellan Health, completed in January 2022, was cited by the company as a major factor in its revenue growth for the year.
- Elsewhere, Centene has been divesting itself of “noncore” subsidiaries in an ongoing review of its portfolio. Divisions that it has sold off include Magellan’s pharmacy and specialty-health units. In May 2023, Centene announced it would divest its A.I.-powered health care analytics company Apixio.
Courtesy of Centene
Company Information
As of 6/5/23
Country
U.S.
Headquarters
St. Louis
Industry
Health Care: Insurance and Managed Care
CEO
Sarah M. London
Website
Company Type
Public
Ticker
CNC
Revenues ($M)
$144,547
Profits ($M)
$1,202
Market Value ($M)
$34,810
Employees
74,300
Market value as of March 31, 2023.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$144,547
14.7%
Profits ($M)
$1,202
-10.8%
Assets ($M)
$76,870
-
Total Stockholder Equity ($M)
$24,057
-
Profit Ratios
Profit as % of Revenues
0.8%
Profits as % of Assets
1.6%
Profits as % of Stockholder Equity
5%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
2.07
EPS % Change (from 2021)
-9.2%
EPS % Change (5 year annual rate)
-2.5%
EPS % Change (10 year annual rate)
75.4%
Total Return
Total Return to Investors (2022)
-0.5%
Total Return to Investors (5 year, annualized)
10.2%
Total Return to Investors (10 year, annualized)
23.1%
Centene Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2022 | $125,98213.4% | $1,347-25.5% | $78,375 | $26,795 |
| 2021 | $111,11548.9% | $1,80836.9% | $68,719 | $25,773 |
| 2020 | $74,63924.2% | $1,32146.8% | $40,994 | $12,551 |
| 2019 | $60,11623.8% | $9008.7% | $30,901 | $10,917 |
| 2018 | $48,57219.3% | $82847.3% | $21,855 | $6,850 |
SHOW MORE
Lists ranking Centene
Latest news for Centene
